Why the study?
Does reduced adrenergic function via guanethidine or phenoxybenzamine affect plasma volume in normal subjects?
Does reduced adrenergic function via guanethidine or phenoxybenzamine affect plasma volume in normal subjects?
Interference with adrenergic function using guanethidine or phenoxybenzamine increases plasma volume and forearm venous compliance in normal subjects, suggesting sympathetic control of venous resistance regulates blood volume.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for sympathetic control of plasma volume; leaves open relevance to patients or outcomes.
Guanethidine was administered to 10 normal subjects in order to examine the effects of reduced adrenergic function on plasma volume. An increase in the plasma volume was observed averaging 21.4% after 1 week, and 12.1% and 13.1% after 2 and 3 weeks of drug administration. A similar change in plasma volume resulted when alphaadrenergic blockade was produced with phenoxybenzamine. These changes occurred in the absence of sodium retention and were associated with attenuation of forearm venous sympathetic reflexes and a rise in forearm venous compliance. The increase in venous compliance which was observed was proportional to the changes in plasma volume in these subjects. Thus, the sympathetic nervous system through its control of venous resistance may provide a means whereby the blood volume can be regulated.
No takes yet. Share an insight, caveat, or question.
Weil et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: